Cost-effectiveness of novel ophthalmology drugs
Third-party funded project
Project title Cost-effectiveness of novel ophthalmology drugs
Principal Investigator(s) Schwenkglenks, Matthias
Co-Investigator(s) Szucs, Thomas
Project Members Bhadhuri, Arjun
Barbier, Michaela
Sutherland, Claudette Simone
Organisation / Research unit Departement Public Health / Pharmazeutische Medizin (Szucs)
Project start 10.12.2010
Probable end 30.06.2020
Status Completed
Abstract

Assessment of cost-effectiveness of novel ophthalmology drugs, from the perspective of the Swiss statutory health insurance and Swiss healthcare system.

Financed by Private Sector / Industry
   

MCSS v5.8 PRO. 0.657 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
14/08/2020